Bausch Health Companies (BHC) Revenue Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 2.94% |
| 10 | Bausch Health Companies | 1.69 Bn | 374.92 Mn | 2.52 Bn | 9.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.09% |
| Dec 31, 2025 | 8.43% |
| Sep 30, 2025 | 9.43% |
| Jun 30, 2025 | 8.75% |
| Mar 31, 2025 | 5.61% |
| Dec 31, 2024 | -29.30% |
| Sep 30, 2024 | 5.94% |
| Jun 30, 2024 | 4.60% |
| Mar 31, 2024 | 2.03% |
| Dec 31, 2023 | 2.85% |
| Sep 30, 2023 | 1.54% |
| Jun 30, 2023 | 9.20% |
| Mar 31, 2023 | -1.14% |
| Dec 31, 2022 | -0.47% |
| Sep 30, 2022 | -2.52% |
| Jun 30, 2022 | -2.95% |
| Mar 31, 2022 | -1.65% |
| Dec 31, 2021 | 50.57% |
| Sep 30, 2021 | -0.39% |
| Jun 30, 2021 | -0.44% |